Ibutilide fumarate: A new class III agent for termination of atrial fibrillation and atrial flutter

Expert Opinion on Investigational Drugs

Volumn 5, Issue 11, 1996, Pages 1511-1522

  Wood, M A ^a   Clemo, H S ^a   Ellenbogen, K A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; atrial flutter; ibutilide

Indexed keywords

ANTIARRHYTHMIC AGENT; IBUTILIDE; IBUTILIDE FUMARATE; PROCAINAMIDE; SOTALOL; UNCLASSIFIED DRUG;

ANIMAL MODEL; CALCIUM CURRENT; CLINICAL TRIAL; DRUG INDICATION; DRUG MECHANISM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; HYPOTENSION; LD 50; NONHUMAN; REVIEW; SODIUM CURRENT;

EID: 0029856703     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.5.11.1511     Document Type: Review

References (0)